Clough Capital Partners’s Veracyte VCYT Stock Holding History

Clough Capital Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-276,260	Closed	-$7.04M	–	239
2023 Q2	$7.04M	Sell	276,260 -63,718	-19%	-$1.54M	0.71%	53
2023 Q1	$7.58M	Buy	339,978 +23,002	+7%	+$556K	0.82%	44
2022 Q4	$7.52M	Sell	316,976 -72,019	-19%	-$1.67M	0.76%	47
2022 Q3	$6.46M	Buy	388,995 +333,500	+601%	+$7.5M	0.69%	28
2022 Q2	$1.1M	Sell	55,495 -92,175	-62%	-$1.86M	0.14%	59
2022 Q1	$4.07M	Sell	147,670 -35,990	-20%	-$1.03M	0.31%	70
2021 Q4	$7.57M	Sell	183,660 -72,400	-28%	-$3.2M	0.51%	57
2021 Q3	$11.9M	Buy	256,060 +29,200	+13%	+$1.27M	0.72%	51
2021 Q2	$9.07M	Buy	226,860 +62,000	+38%	+$2.65M	0.49%	71
2021 Q1	$8.86M	Sell	164,860 -28,300	-15%	-$1.63M	0.4%	70
2020 Q4	$9.45M	Sell	193,160 -30,800	-14%	-$1.43M	0.67%	59
2020 Q3	$7.28M	Buy	223,960 +90,100	+67%	+$2.86M	0.52%	58
2020 Q2	$3.47M	Buy	133,860 +48,200	+56%	+$1.2M	0.34%	77
2020 Q1	$2.08M	Sell	85,660 -136,480	-61%	-$3.44M	0.21%	67
2019 Q4	$6.2M	Sell	222,140 -71,900	-24%	-$1.86M	0.53%	63
2019 Q3	$7.06M	Buy	294,040 +33,440	+13%	+$890K	0.58%	44
2019 Q2	$7.43M	Buy	260,600 +89,400	+52%	+$2.23M	0.73%	54
2019 Q1	$4.28M	Sell	171,200 -225,400	-57%	-$4.3M	0.37%	71
2018 Q4	$4.99M	Buy	396,600 +96,600	+32%	+$1.14M	0.59%	60
2018 Q3	$2.87M	Buy	+300,000	New	+$3.31M	0.27%	74
2016 Q3	–	Sell	-267,547	Closed	-$1.35M	–	207
2016 Q2	$1.35M	Sell	267,547 -649,742	-71%	-$3.48M	0.07%	136
2016 Q1	$4.95M	Sell	917,289 -144,065	-14%	-$852K	0.23%	107
2015 Q4	$7.64M	Sell	1,061,354 -346,882	-25%	-$2.34M	0.36%	85
2015 Q3	$6.61M	Sell	1,408,236 -31,800	-2%	-$303K	0.29%	83
2015 Q2	$16M	Buy	1,440,036 +373,958	+35%	+$3.68M	0.61%	61
2015 Q1	$7.76M	Buy	1,066,078 +49,200	+5%	+$403K	0.26%	113
2014 Q4	$9.82M	Buy	1,016,878 +193,188	+23%	+$1.51M	0.35%	101
2014 Q3	$8.03M	Buy	823,690 +426,490	+107%	+$5.6M	0.3%	99
2014 Q2	$6.8M	Buy	397,200 +143,400	+57%	+$2.06M	0.21%	124
2014 Q1	$4.35M	Buy	253,800 +1,700	+0.7%	+$27.1K	0.14%	138
2013 Q4	$3.65M	Buy	+252,100	New	+$3.28M	0.12%	146

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Clough Capital Partners's VCYT Position: Q3 2023 in Review

Clough Capital Partners sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 276,260 shares — an estimated $7.04M sold.

Clough Capital Partners first reported a position in VCYT in Q4 2013 and held it in 31 quarters. The position peaked at $16M in Q2 2015. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

Clough Capital Partners reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
Clough Capital Partners sold 276,260 Veracyte shares in Q3 2023, an estimated $7.04M.
Clough Capital Partners first reported a position in Veracyte in Q4 2013 and held it in 31 quarters.
Clough Capital Partners's Veracyte position peaked at $16M in Q2 2015.
236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Clough Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.